Advances and challenges in chimeric antigen receptor-natural killer cell immunotherapy for cancer

被引：0
|
作者：
Rafei, Hind [1 ]
Rezvani, Katayoun [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 02期
基金：
美国国家卫生研究院;
关键词：
CAR-NK; immunotherapy; NK cells;
D O I：
10.1111/bjh.19939
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chimeric antigen receptor (CAR)-natural killer (NK)-cell therapy has emerged as a promising strategy in the treatment of haematological malignancies and solid cancers. Leveraging the innate immune properties of NK cells, CAR-NK-cell therapies offer potential advantages for cell therapy, including safety of use in the allogeneic setting and reduced risk of toxicity. This Nutshell provides an overview of the latest advancements in CAR-NK-cell therapy and the challenges that remain.
引用
收藏
页码：443 / 446
页数：4
相关论文
共 50 条
  • [21] Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy
    Chaudhry, Kajal
    Dowlati, Ehsan
    Bollard, Catherine M.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (06) : 643 - 659
  • [22] Chimeric antigen receptor-natural killer cells: a promising sword against insidious tumor cells
    Tahereh Hojjatipour
    Zahra Sharifzadeh
    Amirhosein Maali
    Mehdi Azad
    Human Cell, 2023, 36 : 1843 - 1864
  • [23] Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
    Wang, Yan
    Jin, Shengjie
    Zhuang, Qiqi
    Liu, Na
    Chen, Ruyi
    Adam, Sofia Abdulkadir
    Jin, Jie
    Sun, Jie
    MEDCOMM, 2023, 4 (06):
  • [24] Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
    Shang, Yufeng
    Zhou, Fuling
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [25] Universal and potent chimeric antigen receptor-natural killer (upCAR-NK) cells for B-cell malignancy treatment
    Kwon, Daekee
    Moon, Bo Kyung
    Han, Mijung
    Lee, Tae-Wook
    Lee, Ji-Han
    Kang, Kyung-Sun
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy
    Yuan Hu
    Zhi-gang Tian
    Cai Zhang
    Acta Pharmacologica Sinica, 2018, 39 : 167 - 176
  • [27] Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy
    Hu, Yuan
    Tian, Zhi-gang
    Zhang, Cai
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (02) : 167 - 176
  • [28] Chimeric antigen receptor T cell: A cancer immunotherapy
    Singh, Surjit
    Khasbage, Sameer
    Kaur, Rimple Jeet
    Sidhu, Jaspreet Kaur
    Bhandari, Bharti
    INDIAN JOURNAL OF PHARMACOLOGY, 2022, 54 (03) : 226 - 233
  • [29] Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review
    Hosseini, Mina
    Habibi, Zahra
    Hosseini, Narges
    Abdoli, Sina
    Rezaei, Nima
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (03) : 349 - 366
  • [30] Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges
    Toulouie, Sara
    Johanning, Gary
    Shi, Yihui
    JOURNAL OF CANCER, 2021, 12 (04): : 1212 - 1219
12345